Comparative study on application of 177Lu-labeled rituximab, tetulomab, cetuximab and huA33 monoclonal antibodies to targeted radionuclide therapy

Zakaly Hesham MH; Mostafa Mostafa YA; Dzholumbetov Sergey; Issa Shams A.M.; Tekin Hüseyin Ozan; USLU ERDEMİR RABİYE; Zhukovsky M

Comparative study on application of 177Lu-labeled rituximab, tetulomab, cetuximab and huA33 monoclonal antibodies to targeted radionuclide therapy

Zakaly Hesham MH, Mostafa Mostafa YA, Dzholumbetov Sergey, Issa Shams A.M., Tekin Hüseyin Ozan, USLU ERDEMİR RABİYE, Zhukovsky M

article (Uluslararası, Hakemli) | Yazar(lar): Zakaly Hesham MH, Mostafa Mostafa YA, Dzholumbetov Sergey, Issa Shams A.M., Tekin Hüseyin Ozan, USLU ERDEMİR RABİYE, Zhukovsky M | Yıl: 2020 | Dergi/Kurum: Biomedical Physics & Engineering Express | İndeks: Emerging Sources Citation Index (ESCI) — Zonguldak Bülent Ecevi